Inventor · disambiguated record
Michal Achmatowicz
Also filed as: ACHMATOWICZ MICHAL
1 granted patent·8 pending applications·2 citations·filing 2021–2025
20Inventor score
Top patents by PatentIndex Score
9 records- 0188US12441729B2Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dioneAMGEN INC·Filed 2024·Granted Oct 14, 2025·2 cites·22 claims
- 0263US2024270719A1Crystalline forms of 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrileMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0359US2025115622A1Crystalline Forms Of An MCL-1 InhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 0458US2025122224A1Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397)AMGEN INC·Filed 2023·Application pending·0 cites
- 0558US2024025896A1Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2021·Application pending·0 cites
- 0656US2024400558A1Processes and intermediates for synthesis of adagrasibMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0748US2025019367A1Methods for Separation of EnantiomersMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0845US2025304556A1Processes for preparation of prmt5 inhibitors and intermediates for making the sameMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0940US2023117777A1Methylation of mcl-1 compoundsAMGEN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michal Achmatowicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →